The Fed’s favorite inflation gauge adds to the cooling inflation evidence (0:15). Biogen (BIIB) buys a rare disease drugmaker (3:25). It has never been cheaper to hedge against S&P losses (4:55).Read a transcript of this episode at Seeking Alpha.Show LinksEmployment cost index eases slightly more than expected in Q2Dividend Roundup: Wells Fargo, Visa, IBM, Hasbro, and moreExxon slips after Q2 miss; results helped by higher Permian, Guyana productionPalantir Technologies rises as Wedbush says it's on 'golden track to success'Meta said to plan features to boost retention at Threads as more than half users quitProcter & Gamble gains after organic sales, margins shine in FQ4Chevron confirms Q2 results, expects annual production at low end of guidance
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from Wall Street Breakfast
Transcribed and ready to explore now
China hits back with 125% tariffs
11 Apr 2025
Wall Street Breakfast
TSMC revenue surges on pre-tariff rush
10 Apr 2025
Wall Street Breakfast
Stocks to the moon as Trump backs off trade war (except for China)
09 Apr 2025
Wall Street Breakfast
Easter spending to hop to $23.6B despite uncertainty
09 Apr 2025
Wall Street Breakfast
Musk reportedly asked Trump to reverse tariffs
08 Apr 2025
Wall Street Breakfast
Medicare bump lifts insurers
08 Apr 2025
Wall Street Breakfast